Quantum X Labs Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $86.7M
- Price
- $4.02
- % Change (Daily % change from the live per-ticker quote feed.)
- -1.71%
- Volume
- 43.9K
About
Quantum X Labs Inc is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of quantum technologies and intellectual property across sectors including navigation, precision timing, and cybersecurity.
Quick stats
Shares outstanding21.6M
Computed float6.6M
Float / shares30.8%
Key info
SectorTechnology
IndustryInformation Technology Services
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000797542
Websitehttps://quantumxlabs.xyz
AI Summary
AI-generated1/30
minorbullishoperations update
QuantumXLabs Reports Approximately 16.8x Acceleration Over CPU-Based Computing in Quantum-Enabled Analysis of More Than 7 Billion Gene Combinations Using Real-World Clinical Data
Quantum X Labs reported its GPU-accelerated quantum-simulation platform achieved roughly a 16.8x speedup over a CPU-only implementation, analyzing more than 7.3 billion possible three-gene combinations on real clinical gene-expression data.
The benchmark ran on an AWS g4dn.16xlarge instance with a single NVIDIA T4 GPU and IBM Qiskit Aer, cutting analysis time from about 8.4 hours to about 0.5 hours while producing the same ~22.2 million correlated gene triplets.
The company cautioned the benchmark evaluated computational performance only and did not establish clinical validity or predictive value of any gene combinations; Quantum X plans to progress toward larger datasets and eventual execution on quantum hardware.
Red flags
- Benchmark based on only 11 patients and 3,531 gene features — very small dataset
- Release explicitly disclaims clinical validity, predictive value, or utility of identified gene combinations
- Promotional 'milestone' release from a small-cap multi-segment holding-style technology company with no revenue or commercial metrics disclosed